Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Uthaipaisanwong et al. (2020): Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study  + (Female n (%): 48 (100))
• Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients  + (Female n (%): 58 (48.3))
• Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial  + (Female n (%): 73 (100))
• Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group  + (Female n (%): 73 (29))
• Khodabakhshi et al. (2019): Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study  + (Female n (%): 77 (100))
• Johnson et al. (2010): Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain  + (Female n (%): 82 (46) Male n (%): 95 (54))
• Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial  + (Female n = 10 (17.86%); male n = 46 (82.14%))
• Montazeri et al. (2013): Effect of Herbal Therapy to Intensity Chemotherapy-Induced Nausea and Vomiting in Cancer Patients  + (Female: 40.9 %)
• Bossi et al. (2017): A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin  + (Female: Intervention vs. Placebo: 31.4 % vs. 37.4 % Female: n = 84 Male: n = 160)
• Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597  + (Female: intervention arm 51%, placebo arm 52%)
• Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy  + (Gender of the participants: female = 48 (66%); male = 25 (34%))
• Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy  + (Gender per arm in n(%): Enzyme-arm: male= 33 (91.7%); female= 3 (8.3%) Placebo-arm: male= 24 (72.7%); female= 9 (36.4%))
• Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente  + (Gender per arm: Enzyme-arm: male = 23 (84.6%); female = 2(15.4%) Control-arm: male = 22(92%); female = 4(8%))
• Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial  + (Gender per arm: Aloe arm: 19 (29.7%) male; 13 female (20.3%) Placebo arm: 19 (29.7%) male; female (20.3%))
• Lissoni et al. (1998): Biotherapy with the Pineal Immunomodulating Hormone Melatonin versus Melatonin plus Aloe vera in Untreatable Advanced Solid Neoplasms  + (Gender per arm: Aloe arm: female = 37.5% Control arm: female= 38.5%)
• Marucci et al. (2017): Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer  + (Gender per arm: Aloe arm: female = 4 (7.5%); male = 49 (92.5%) Placebo arm: female = 10 (19.6%); male = 41 (80.4%))
• Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study  + (Gender per arm: Aloe arm: male = 27 (90%); female = 3 (10%) Placebo arm: male = 20 (65%); female 11 (35%))
• Lissoni et al. (2009): A Randomized Study of Chemotherapy versus Biochemotherapy with Chemotherapy plus Aloe arborescens in Patients with Metastatic Cancer  + (Gender per arm: Aloe arm: male = 67; female = 54 Control arm: male = 65; female = 54)
• Sahebjamee et al. (2015): Comparative Efficacy of Aloe vera and Benzydamine Mouthwashes on Radiation-induced Oral Mucositis: A Triple-blind, Randomised, Controlled Clinical Trial  + (Gender per arm: Aloe arm: male = 8 (61.5%); female = 5 (38.5%) Placebo arm: male = 12 (92.3%); female = 1 (7.7%))
• Su et al. (2004): Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms  + (Gender per arm: Aloe arm: male = 82%; female = 17.9% Placebo arm: male = 77%; female = 23.3%)
• Vinzenz et al. (1992): Die Therapie der radiogenen Mukositis mit Enzymen  + (Gender per arm: Enzyme arm: female = 3 (15.8%); male = 16 (84.2%) Control arm: female = 5 (25%); male = 15 (75%))
• Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers  + (Gender per arm: Enzyme-arm: male= 34(64%); female= 16(36%) Control-arm: male= 35(74%); female= 12(26%))
• Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients  + (Intervention arm 67%, control arm 67.6% male)
• Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer  + (Intervention arm: 13 male, 3 female Control arm: 11 male, 4 female)
• Marx et al. (2017): The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial  + (Intervention arm: 16 % woman; Placebo arm: 16 % woman)

• Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial  + (Intervention arm: 16 (53.3%) male Control arm: 14 (46.7%) male)

• Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial  + (Intervention arm: 25 (62.5%) male, 15 (37.5%) female placebo arm: 29 (72.5%), 15 (37.5%) female)
• Sangthawan et al. (2015): Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy  + (Intervention arm: 33 (92%) male, 3 (8%) female Placebo arm: 31 (86%) male, 5 (14%) female)
• Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer  + (Intervention arm: 4:6 (male: female) Placebo arm: 5:9 (male:female))
• Sangthawan et al. (2013): A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients  + (Intervention arm: 65 (90%) male, 7 (10%) female Placebo arm: 60 (83%) male, 12 (17%) female)
• Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain  + (Intervention arm: female n = 95 (48%) Placebo arm: female n = 88 (44.2%))
• Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial  + (Intervention arm: n=12 female, n=13 male Placebo arm: n=12 female, n=13 male)
• Moslemi et al. (2014): Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial  + (Intervention arm: n=12 male, n=8 female placebo arm: n=9 male, n=8 female)
• Lin et al. (2009): Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis  + (Intervention arm: n=14 male, n=3 female Placebo arm: n=13 male, n=4 female)
• Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer  + (Intervention arm: n=15 male and n=1 female Control arm: n=24 male, n=0 female)
• Urashima et al. (2019): Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial  + (Intervention arm: n=173 (69%) male, n=78 (31%) female placebo arm: n=103 (62%) male, n=63 (38%) female)
• Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial  + (Intervention arm: n=32 (64%) male, n=18 (36%) female; placebo arm: n=27 (49%) male, n=28 (51%) female)
• Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study  + (Intervention arm: n=40 (81.6%) male, n=9 (18.4%) female Placebo arm: n=43 (89.6%) male, n=5 (10.4%) female)
• Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study  + (Intervention arm: n=40 (81.6%) male, n=9 (18.4%) female Placebo arm: n=43 (89.6%) male, n=5 (10.4%) female)
• Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial  + (Intervention arm: n=41 (59%) male, n=28 (41%) female; placebo arm: n=38 (54%) male, n=32 (46%) female)
• Paur et al. (2017): Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA  + (Male n (%): 86 (100))
• Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer  + (Male n (%): 92 (100))
• Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study  + (Male n(%) per arm: Green tea arm: 2 (13), Metronidazole arm: 1 (7) Female n(%) per arm: Green tea arm: 13 (87), Metronidazole arm: 14 (93))
• Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy  + (Male n(%) per arm: Green tea arm: 9 (42.9), placebo arm: 14 (66.7) Female n(%) per arm: Green tea arm: 12 (57.1), placebo arm: 7 (33.3))
• Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer  + (Male n(%) per arm: Selenium arm: 25 (67.9), placebo arm: 25 (73.5) Female n(%) per arm: Selenium arm: 12 (32.1), placebo arm: 9 (26.5))
• Li et al. (2018): Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial  + (Male n(%) per group: ginger-group: 53 (74.65), placebo-group: 47 (68.12) Female n(%) per group: ginger-group: 18 (25.35), placebo-group: 22 (31.88))
• Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients  + (Male n=31, female n=8)
• Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…)  + (Male per arm: THC = 54% Cannabis extract = 56% Placebo = 52%)
• Freedland et al. (2020): A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2)  + (Male, n (%): 57 (100))
• Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies  + (Male, n(%) per arm: Sativex = 106 (53.0) Placebo = 97 (48.7) Female, n(%) per arm: Sativex = 194 (47.0) Placebo = 102 (51.3))
• Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients  + (N (%) of men per arm: - intervention: 223 (82) - placebo: 203 (76))